Abstract
Abstract only
- Title
- Characterization and predictors of long term (≥ 10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer patients
- Creators
- Michael Friedlander - Prince of Wales HospitalJohn K. Chan - Palo Alto Medical FoundationJim Java - University of Rochester Medical CenterDeborah K Armstrong - Johns Hopkins UniversityMaurie Markman - Cancer Treatment Centers of AmericaThomas J. Herzog - University of CincinnatiBradley J. Monk - University of ArizonaFloor Jenniskens Backes - The Ohio State UniversityAngeles Alvarez Secord - Duke Medical CenterAlbert J. Bonebrake - Cancer Research for the OzarksPeter Graham Rose - Cleveland ClinicKrishnansu Sujata Tewari - University of California, IrvineRobert S. Mannel - Oklahoma State University Oklahoma CitySamuel S. Lentz - Atrium Health Wake Forest BaptistMelissa Ann Geller - University of Minnesota Medical CenterLarry J. Copeland - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Publication Details
- Journal of clinical oncology, Vol.36(15_suppl), pp.5556-5556
- Identifiers
- 991005968799502656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article